April 2 (Reuters) - Esperion Therapeutics Inc ESPR.O:
ESPERION THERAPEUTICS INC - ENTERS FIRST AMENDMENT TO CREDIT AGREEMENT ON APRIL 2, 2026 - SEC FILING
ESPERION THERAPEUTICS INC - INCURS $25 MILLION IN ADDITIONAL TERM LOANS ON APRIL 2, 2026 - SEC FILING
Source text: [ID:n0001628280-26-023196]